See the pitch deck Theranica used for a $25 million Series C · page 13 of 22
The slide uses a bar chart to visually demonstrate that Nerivio has a significantly lower adverse event (AE) rate compared to pharmaceutical alternatives.
Pitch deck · competitive_analysis · compare_peers · dense density
Slide locked Sign in to view
Slide schematic 5/7
callout 0/1 chart 1/1 image 1/1 list 1/1 metric 0/1 paragraph 1/1 title 1/1
2 without position callout 1 · metric 1
calloutmetric · primary
Components 7
callout bar-vertical photo bullet primary paragraph headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1